https://www.selleckchem.com/pr....oducts/pd-166866.htm
9541 and 1.0469 at 1month. The incidence of regrowth was 20.45% and the largest 95% LOA of regrowth nodules was between 0.9028 and 1.284 at 12months. At the same follow-up period, VRR had a narrower 95% LOA than volume. Compared with volume ≥10 ml, nodules 10 ml revealed a larger 95% LOA in both the volume and VRR. The inter-observer reliability of the US measurements of benign thyroid nodules during the follow-up period of RFA was acceptable. The variation by different observers could not affect the evaluation of efficacy. The in